Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21), a glucose and lipid metabolic regulator, has recently been demonstrated to be associated with cardiovascular diseases (CVD) such as carotid atherosclerosis, coronary heart disease and carotid artery plaques. However, the relationship between circulati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovasc Diabetol
Hauptverfasser: Xiao, Yang, Liu, Lingjiao, Xu, Aimin, Zhou, Pengcheng, Long, Zhaofeng, Tu, Yiting, Chen, Xiaoyan, Tang, Weili, Huang, Gan, Zhou, Zhiguang
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2015
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475300/
https://ncbi.nlm.nih.gov/pubmed/26047614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0229-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge